Luvox and Lamzede drug interactions - a phase IV clinical study of FDA data
Summary:
We study 13,450 people who take Luvox (fluvoxamine maleate) and Lamzede (velmanase alfa-tycv). There is no drug interaction reported.
The study analyzes what interactions people have when they take Luvox and Lamzede. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Luvox?
Luvox has active ingredients of fluvoxamine maleate. It is often used in obsessive-compulsive disorder. eHealthMe is studying from 13,439 Luvox users. Check the latest studies of Luvox.
What is Lamzede?
Lamzede has active ingredients of velmanase alfa-tycv. eHealthMe is studying from 11 Lamzede users. Check the latest studies of Lamzede.
No report is found.
Do you take Luvox and Lamzede?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Related publications that referenced our studies
- Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
- Pang, T., & Gudi, A., "Chest pain following the use of fluvoxamine in depression", Proceedings of Singapore Healthcare, 2018 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on fluvoxamine maleate and velmanase alfa-tycv (the active ingredients of Luvox and Lamzede, respectively), and Luvox and Lamzede (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Singulair and Augmentin drug interactions for men aged 50-59 - 4 seconds ago
- Nucala and Abdominal Pain for Women aged 60+ - 9 seconds ago
- Nucala and Stomachache for Women aged 60+ - 9 seconds ago
- Zyrtec and Stevens Johnson Syndrome for Women aged 30-39 - 10 seconds ago
- Nucala and Stomach Pain for Women aged 60+ - 10 seconds ago
- Zyrtec and Sjs for Women aged 30-39 - 10 seconds ago
- Nucala and Pain - Abdomen for Women aged 60+ - 10 seconds ago
- Zyrtec and Toxic Epidermal Necrolysis for Women aged 30-39 - 11 seconds ago
- Nucala and Abdominal Cramps for Women aged 60+ - 11 seconds ago
- Zyrtec and Stevens-Johnson Syndrome for Women aged 30-39 - 11 seconds ago